SC Questions 10X Cancer Drug Price Gap, Gives Centre Two Weeks For Action

By NDTV Profit

Community Score: 50% | 9 views | 2w

0 community ratings: null thumbs up, null thumbs down

The Supreme Court has questioned the sharp gap between the supply price and MRP of cancer medicines, citing a drug supplied at around ₹2,700 but carrying an MRP of ₹27,000. The court has given the Centre two weeks to examine the issue and has also raised concerns over hospitals requiring patients to buy medicines from their own pharmacies. The matter is expected to come up again on October 12. #CancerDrugs #SupremeCourt #MedicinePrices #Healthcare #CancerTreatment For more videos subscribe to our channel: https://www.youtube.com/@NDTVProfitIndia Visit NDTV Profit for more news: https://www.ndtvprofit.com/ Don't enter the stock market unaware. Read all Research Reports here: https://www.ndtvprofit.com/research-reports Follow NDTV Profit here Twitter: https://twitter.com/NDTVProfitIndia , https://twitter.com/NDTVProfit LinkedIn: https://www.linkedin.com/company/ndtvprofit Instagram: https://www.instagram.com/ndtvprofit/ Facebook: https://www.facebook.com/NDTVProfit/ $MetaTags$1#Digi

Tags: cancer drugs, cancer, cancer drugs markup, cancer drug prices, cancer medicine prices India, Supreme Court cancer drugs, SC cancer drug pricing, cancer drug MRP, ₹2700 drug ₹27000 MRP, medicine price regulation India, Supreme Court medicine prices, cancer treatment cost India, cancer medicines India, drug pricing India, pharma pricing India, cancer treatment expenses, healthcare costs India, cancer patients India, government health schemes, news